Correlation Between Opus Genetics, and Vigil Neuroscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Opus Genetics, and Vigil Neuroscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opus Genetics, and Vigil Neuroscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opus Genetics, and Vigil Neuroscience, you can compare the effects of market volatilities on Opus Genetics, and Vigil Neuroscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opus Genetics, with a short position of Vigil Neuroscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opus Genetics, and Vigil Neuroscience.

Diversification Opportunities for Opus Genetics, and Vigil Neuroscience

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Opus and Vigil is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Opus Genetics, and Vigil Neuroscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vigil Neuroscience and Opus Genetics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opus Genetics, are associated (or correlated) with Vigil Neuroscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vigil Neuroscience has no effect on the direction of Opus Genetics, i.e., Opus Genetics, and Vigil Neuroscience go up and down completely randomly.

Pair Corralation between Opus Genetics, and Vigil Neuroscience

Considering the 90-day investment horizon Opus Genetics, is expected to under-perform the Vigil Neuroscience. But the stock apears to be less risky and, when comparing its historical volatility, Opus Genetics, is 1.69 times less risky than Vigil Neuroscience. The stock trades about -0.06 of its potential returns per unit of risk. The Vigil Neuroscience is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  1,043  in Vigil Neuroscience on September 2, 2024 and sell it today you would lose (796.00) from holding Vigil Neuroscience or give up 76.32% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Opus Genetics,  vs.  Vigil Neuroscience

 Performance 
       Timeline  
Opus Genetics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Opus Genetics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Opus Genetics, is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
Vigil Neuroscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vigil Neuroscience has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Opus Genetics, and Vigil Neuroscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Opus Genetics, and Vigil Neuroscience

The main advantage of trading using opposite Opus Genetics, and Vigil Neuroscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opus Genetics, position performs unexpectedly, Vigil Neuroscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vigil Neuroscience will offset losses from the drop in Vigil Neuroscience's long position.
The idea behind Opus Genetics, and Vigil Neuroscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like